Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Pediatrics · Glycogen Storage Disease Type Ia

Recognizing Early Symptoms and Warning Signs

At a Glance

Early symptoms of Glycogen Storage Disease Type Ia (GSD Ia) in infants include a protruding abdomen due to an enlarged liver, a doll-like face, and thin extremities. A critical metabolic warning sign is severe fasting hypoglycemia, which causes extreme lethargy, sweating, and rapid breathing.

Recognizing the early symptoms of Glycogen Storage Disease Type Ia (GSD Ia) is the first step toward gaining control over the condition. Because infants cannot communicate how they feel, the disease often reveals itself through physical changes and metabolic “cries for help” that parents can learn to identify.

The Classic Physical Appearance

Infants with GSD Ia often share a very specific physical profile that helps doctors recognize the condition.

  • Protruding Abdomen: This is one of the most common early signs. It is caused by hepatomegaly, which is the medical term for an enlarged liver [1][2]. Because the liver cannot release stored sugar, it becomes packed with excess glycogen (stored sugar) and fat, causing it to swell and push the belly outward [3][4].
  • “Doll-Like” Face: You may hear doctors describe your child’s face as “cherubic” or “doll-like.” This appearance is caused by the accumulation of fat in the cheeks, a side effect of how the body reshapes its fat stores when it cannot access sugar in the liver [5][6].
  • Thin Extremities: While the belly and face may appear full, the arms and legs often look thin due to growth retardation or poor muscle development, as the body lacks the consistent energy it needs to grow normally [7][1].

It is highly reassuring to know that these physical traits—including the protruding belly and the “doll-like” face—often improve and normalize significantly once the child achieves metabolic stability on their strict diet [8][9].

Metabolic Warning Signs

Beyond what you can see, GSD Ia causes internal shifts that create visible symptoms:

  • Severe Fasting Hypoglycemia: This is the hallmark of the disease. Within just a few hours of fasting (not eating), an infant’s blood sugar can drop to life-threatening levels [10][11]. Signs include extreme irritability, sweating, tremors, or lethargy (excessive sleepiness) that improves immediately after a feeding [1].
  • Hyperventilation: If you notice your child breathing very rapidly, it may be a sign of lactic acidosis. When the body cannot make enough glucose, it produces too much lactic acid [5]. This acid builds up in the blood, and the body tries to “blow off” the excess acid by breathing faster [12][13].
  • Failure to Thrive: Because the body is in a constant state of metabolic stress, infants may not gain weight or reach developmental milestones at the expected rate [7][1].

Emergency Action Plan for Hypoglycemia

If your child shows signs of severe lethargy, unresponsiveness, or an inability to wake up, this is a medical emergency. You must have a clear Emergency Action Plan [6][14]:

  1. Immediate Action: Administer emergency fast-acting glucose (such as a glucose gel) to their gums immediately if they are awake enough to not choke [6].
  2. Call 911: If your child cannot safely swallow or remains unresponsive, call 911 or go to the nearest emergency room immediately [6][14]. Do not wait for symptoms to improve on their own.

The Risk of a Late Diagnosis

In some cases, the symptoms may be milder, or the child may have a slightly higher “fasting tolerance” (the ability to go longer without food) [15]. This can sometimes lead to a late diagnosis, occasionally not occurring until late childhood or even adulthood [2]. However, even in mild cases, the underlying metabolic issues—like high triglycerides (blood fats) or elevated liver enzymes—can still cause long-term damage if not managed through a strict diet [2][16]. Early detection, even in milder cases, is essential to prevent complications such as kidney disease or liver tumors later in life [8][17].

Return to the Understanding Your Child’s GSD Ia Diagnosis.

Common questions in this guide

Why do infants with GSD Ia have a protruding belly?
A protruding belly in GSD Ia is caused by an enlarged liver, known medically as hepatomegaly. Because the liver cannot properly release stored sugar into the bloodstream, it becomes packed with excess glycogen and fat, causing it to swell outward.
What causes the 'doll-like' face in infants with GSD Ia?
The 'doll-like' or cherubic face is caused by the accumulation of fat in the cheeks. This occurs as a side effect of the body reshaping its fat stores when it cannot access sugar in the liver. These features typically improve once a child is stabilized on a strict diet.
What are the warning signs of fasting hypoglycemia in my baby?
Severe low blood sugar can develop within just a few hours of not eating. Signs to watch for include extreme irritability, excessive sweating, tremors, and profound sleepiness or lethargy that improves immediately after a feeding.
Why might my child with GSD Ia breathe very rapidly?
Rapid breathing, or hyperventilation, can be a sign of lactic acidosis. When an infant's body cannot produce enough glucose, it creates excess lactic acid. The rapid breathing is the body's attempt to clear this excess acid from the blood.
When should I use the emergency glucose gel?
Emergency fast-acting glucose gel should be applied to your child's gums immediately if they show signs of severe lethargy but are awake enough not to choke. If your child cannot safely swallow or is unresponsive, call 911 or go to the nearest emergency room immediately.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you explain exactly what 'doll-like face' means for my child and if it will change as they get older?
  2. 2.What is my child's current lactate level, and how often should we be checking for lactic acidosis?
  3. 3.How can we tell the difference between normal infant breathing and hyperventilation caused by acid buildup?
  4. 4.Is the size of my child's liver (hepatomegaly) impacting their ability to eat full meals?
  5. 5.Are my child's symptoms considered 'classic' or 'mild' based on their genetic testing and blood work?
  6. 6.Under what specific circumstances should we use the emergency fast-acting glucose gel?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Clinical features of gout in adult patients with type Ia glycogen storage disease: a single-centre retrospective study and a review of literature.

    Xu N, Han X, Zhang Y, et al.

    Arthritis research & therapy 2022; (24(1)):58 doi:10.1186/s13075-021-02706-5.

    PMID: 35219330
  2. 2

    Successful treatment of diabetes associated with glycogen storage disease type Ia.

    Yuan X, Ma W, Wu X, et al.

    Diabetic medicine : a journal of the British Diabetic Association 2021; (38(2)):e14373 doi:10.1111/dme.14373.

    PMID: 32740965
  3. 3

    Serum sex hormone-binding globulin levels are reduced and inversely associated with intrahepatic lipid content and saturated fatty acid fraction in adult patients with glycogen storage disease type 1a.

    Simons PIHG, Valkenburg O, Telgenkamp I, et al.

    Journal of endocrinological investigation 2022; (45(6)):1227-1234 doi:10.1007/s40618-022-01753-2.

    PMID: 35132570
  4. 4

    Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia.

    Cho JH, Kim GY, Mansfield BC, Chou JY

    Biochemical and biophysical research communications 2018; (498(4)):925-931 doi:10.1016/j.bbrc.2018.03.083.

    PMID: 29545180
  5. 5

    Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.

    Hoogerland JA, Peeks F, Hijmans BS, et al.

    Journal of inherited metabolic disease 2021; (44(4)):879-892 doi:10.1002/jimd.12380.

    PMID: 33739445
  6. 6

    A triple-blinded crossover study to evaluate the short-term safety of sweet manioc starch for the treatment of glycogen storage disease type Ia.

    Monteiro VCL, de Oliveira BM, Dos Santos BB, et al.

    Orphanet journal of rare diseases 2021; (16(1)):254 doi:10.1186/s13023-021-01877-3.

    PMID: 34082801
  7. 7

    A patient with glycogen storage disease type Ia combined with chronic hepatitis B infection: a case report.

    Wang W, Yu R, Tan W, et al.

    BMC medical genetics 2019; (20(1)):85 doi:10.1186/s12881-019-0816-9.

    PMID: 31109299
  8. 8

    A case study of glycogen storage disease type Ia presenting with multiple hepatocellular adenomas: an analysis by gadolinium ethoxybenzyl-diethylenetriamine-pentaacetic acid magnetic resonance imaging.

    Li X, Jing H, Cheng L, et al.

    Quantitative imaging in medicine and surgery 2021; (11(6)):2785-2791 doi:10.21037/qims-20-746.

    PMID: 34079743
  9. 9

    Case Report: Glycogen Storage Disease Type Ia in a Chinese Child Treated With Growth Hormone.

    Wu S, Guo S, Fu L, et al.

    Frontiers in pediatrics 2022; (10()):921323 doi:10.3389/fped.2022.921323.

    PMID: 35783312
  10. 10

    Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia.

    Arnson B, Kang HR, Brooks ED, et al.

    Molecular therapy. Methods & clinical development 2023; (29()):108-119 doi:10.1016/j.omtm.2023.03.001.

    PMID: 37021039
  11. 11

    Efficacious genome editing in infant mice with glycogen storage disease type Ia.

    Arnson B, Ilich E, von Beck T, et al.

    JCI insight 2025; (10(18)).

    PMID: 40762955
  12. 12

    Recoverable, Record-High Lactic Acidosis in a Patient with Glycogen Storage Disease Type 1: A Mixed Type A and Type B Lactate Disorder.

    Oster Y, Wexler ID, Heyman SN, Fried E

    Case reports in medicine 2016; (2016()):4362743 doi:10.1155/2016/4362743.

    PMID: 27974893
  13. 13

    [Hyperlactatemia induced by inhaled β2 agonists: An underrecognized side effect. Report of two cases].

    David C, Pouchot J, Ranque B

    La Revue de medecine interne 2019; (40(6)):400-403 doi:10.1016/j.revmed.2018.11.010.

    PMID: 30541659
  14. 14

    Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.

    La Rose AM, Bazioti V, Hoogerland JA, et al.

    Molecular metabolism 2021; (53()):101265 doi:10.1016/j.molmet.2021.101265.

    PMID: 34091064
  15. 15

    A patient with glycogen storage disease type IA combined with hepatic adenoma: A case report.

    Yin M, Chang L, Jiang P, et al.

    Genes & diseases 2023; (10(3)):701-704 doi:10.1016/j.gendis.2022.08.002.

    PMID: 37396534
  16. 16

    Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy.

    Okechuku GO, Shoemaker LR, Dambska M, et al.

    Journal of inherited metabolic disease 2017; (40(5)):703-708 doi:10.1007/s10545-017-0054-2.

    PMID: 28612263
  17. 17

    Liver-Directed Gene Therapy Mitigates Early Nephropathy in Murine Glycogen Storage Disease Type Ia.

    Lee C, Pratap K, Zhang L, et al.

    Journal of inherited metabolic disease 2025; (48(4)):e70048 doi:10.1002/jimd.70048.

    PMID: 40443300

This page provides educational information on identifying the early signs of GSD Ia. It does not replace professional medical advice. Always seek immediate emergency care if your child experiences severe lethargy, unresponsiveness, or medical distress.

Get notified when new evidence is published on Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.